Cambridge, U.K.-based Horizon Discovery Group plc said Darrin Disley decided to step down as CEO to pursue other business interests.
Richard Vellacott, the gene editing company's CFO and deputy CEO, was appointed interim CEO while Ian Gilham, the company's board chairman, was named interim executive chairman.